Insider Transactions Reported by 13 Insiders of Krystal Biotech, Inc.

Symbol
KRYS on Nasdaq
Location
Pittsburgh, PA

Insiders trading volume in the past year

Krystal Biotech, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Krish S. Krishnan President and CEO, Director, 10%+ Owner $440,076,632 -$25,104,447 -5.4% 04 Mar 2026
Suma M. Krishnan President, R&D, Director, 10%+ Owner $418,793,937 -$25,105,439 -5.7% 04 Mar 2026
Dino A. Rossi Director $20,624,911 -$4,953,694 -19% 19 Feb 2026
Daniel Janney Director $20,241,071 -$19,402,207 -49% 27 Feb 2026
Kathryn Romano Chief Accounting Officer $7,696,124 -$3,602,405 -32% 27 Feb 2026
Laurent Louis Jean Goux EVP, Head of International $250,565 01 Mar 2026
John C. Thomas EVP, General Counsel $175,041 01 Mar 2026
Andrew C. Orth Chief Commercial Officer $13,000 09 Jun 2023
Christopher Mason Director 30 Jun 2025
Catherine Mazzacco Director 30 Jun 2025
Julian S. Gangolli Director 30 Jun 2025
Everett Rand Sutherland Director 30 Jun 2025
Jing L. Marantz Chief Business Officer 31 Jan 2022

Recent Insider Transactions by Companies or Individuals for Krystal Biotech, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Suma M. Krishnan KRYS Common Stock Sale -1.75% $6,580,270 $263.21 -25,000 1,403,155 04 Mar 2026 Direct
Krish S. Krishnan KRYS Common Stock Sale -1.67% $6,579,164 $263.17 -25,000 1,475,253 04 Mar 2026 Direct
Kathryn Romano KRYS Common Stock Sale -3.24% $200,700 $267.60 -750 22,366 02 Mar 2026 Direct
Kathryn Romano KRYS Common Stock Tax liability -13.3% -3,502 22,806 27 Feb 2026 Direct
Kathryn Romano KRYS Common Stock Options Exercise 44.7% 8,050 26,068 27 Feb 2026 Direct
Kathryn Romano KRYS Restricted Stock Units Award 5,442 5,442 27 Feb 2026 Direct
Kathryn Romano KRYS Stock Option (Right to Buy) Award 13,575 13,575 27 Feb 2026 Direct
Kathryn Romano KRYS Restricted Stock Units Options Exercise -25% -550 1,650 27 Feb 2026 Direct
Kathryn Romano KRYS Performance Stock Units Options Exercise -100% -7,500 0 27 Feb 2026 Direct
Suma M. Krishnan KRYS Common Stock Tax liability -1.23% -18,528 1,482,825 27 Feb 2026 By Spouse
Suma M. Krishnan KRYS Common Stock Options Exercise 2.77% 40,725 1,509,075 27 Feb 2026 By Spouse
Suma M. Krishnan KRYS Common Stock Tax liability -0.84% -12,056 1,425,975 27 Feb 2026 Direct
Suma M. Krishnan KRYS Common Stock Options Exercise 1.88% 26,500 1,436,211 27 Feb 2026 Direct
Suma M. Krishnan KRYS Performance Stock Units Award 43,536 43,536 27 Feb 2026 Direct
Suma M. Krishnan KRYS Restricted Stock Units Award 7,256 7,256 27 Feb 2026 Direct
Suma M. Krishnan KRYS Stock Option (Right to Buy) Award 18,100 18,100 27 Feb 2026 Direct
Suma M. Krishnan KRYS Restricted Stock Units Options Exercise -25% -4,000 12,000 27 Feb 2026 Direct
Suma M. Krishnan KRYS Performance Stock Units Options Exercise -100% -22,500 0 27 Feb 2026 Direct
Krish S. Krishnan KRYS Common Stock Tax liability -0.84% -12,056 1,425,975 27 Feb 2026 By Spouse
Krish S. Krishnan KRYS Common Stock Options Exercise 1.88% 26,500 1,436,211 27 Feb 2026 By Spouse
Krish S. Krishnan KRYS Common Stock Tax liability -1.23% -18,528 1,482,825 27 Feb 2026 Direct
Krish S. Krishnan KRYS Common Stock Options Exercise 2.77% 40,725 1,509,075 27 Feb 2026 Direct
Krish S. Krishnan KRYS Restricted Stock Units Award 18,140 18,140 27 Feb 2026 Direct
Krish S. Krishnan KRYS Stock Option (Right to Buy) Award 45,249 45,249 27 Feb 2026 Direct
Krish S. Krishnan KRYS Performance Stock Units Options Exercise -100% -26,250 0 27 Feb 2026 Direct
Krish S. Krishnan KRYS Restricted Stock Units Options Exercise -45.7% -14,475 17,175 27 Feb 2026 Direct
Daniel Janney KRYS Common Stock Sale -13.9% $3,252,824 $275.59 -11,803 73,293 27 Feb 2026 Directly beneficially owned by Alta Bioequities, L.P.
Daniel Janney KRYS Common Stock Sale -8.34% $2,133,679 $275.63 -7,741 85,096 26 Feb 2026 Directly beneficially owned by Alta Bioequities, L.P.
Daniel Janney KRYS Common Stock Sale -0.75% $192,500 $275.00 -700 92,837 25 Feb 2026 Directly beneficially owned by Alta Bioequities, L.P.
Daniel Janney KRYS Common Stock Sale -12.9% $3,709,850 $268.34 -13,825 93,537 24 Feb 2026 Directly beneficially owned by Alta Bioequities, L.P.
Daniel Janney KRYS Common Stock Sale -100% $10,113,354 $266.88 -37,895 0 24 Feb 2026 Direct
Daniel Janney KRYS Common Stock Options Exercise 37,895 37,895 24 Feb 2026 Direct
Daniel Janney KRYS Stock Option (Right to Buy) Options Exercise -100% -37,895 0 24 Feb 2026 Direct
Dino A. Rossi KRYS Common Stock Sale -19.4% $4,953,694 $261.41 -18,950 78,691 19 Feb 2026 Direct
Dino A. Rossi KRYS Common Stock Options Exercise 24.1% 18,950 97,641 19 Feb 2026 Direct
Dino A. Rossi KRYS Stock Option (Right to Buy) Options Exercise -100% -18,950 0 19 Feb 2026 Direct
Kathryn Romano KRYS Common Stock Gift -3.88% -750 18,568 09 Feb 2026 Direct
Kathryn Romano KRYS Common Stock Sale -39.3% $3,401,705 $272.14 -12,500 19,318 09 Feb 2026 Direct
Kathryn Romano KRYS Common Stock Options Exercise 64.7% 12,500 31,818 09 Feb 2026 Direct
Kathryn Romano KRYS Stock Option (Right to Buy) Options Exercise -50% -12,500 12,500 09 Feb 2026 Direct
Suma M. Krishnan KRYS Common Stock Gift -0.34% -5,000 1,478,056 05 Dec 2025 By Spouse
Krish S. Krishnan KRYS Common Stock Gift -0.34% -5,000 1,478,056 05 Dec 2025 Direct
Suma M. Krishnan KRYS Common Stock Sale -1.66% $5,503,395 $220.14 -25,000 1,483,056 04 Dec 2025 By Spouse
Suma M. Krishnan KRYS Common Stock Sale -1.74% $5,503,938 $220.16 -25,000 1,413,711 04 Dec 2025 Direct
Krish S. Krishnan KRYS Common Stock Sale -1.74% $5,503,938 $220.16 -25,000 1,413,711 04 Dec 2025 By Spouse
Krish S. Krishnan KRYS Common Stock Sale -1.66% $5,503,509 $220.14 -25,000 1,483,056 04 Dec 2025 Direct
Suma M. Krishnan KRYS Common Stock Sale -0.09% $208,350 $150.00 -1,389 1,508,056 16 Jul 2025 By Spouse
Suma M. Krishnan KRYS Common Stock Sale -0.11% $229,350 $150.00 -1,529 1,438,711 16 Jul 2025 Direct
Krish S. Krishnan KRYS Common Stock Sale -0.11% $229,350 $150.00 -1,529 1,438,711 16 Jul 2025 By Spouse
Krish S. Krishnan KRYS Common Stock Sale -0.09% $208,350 $150.00 -1,389 1,508,056 16 Jul 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.